Forfivo Tablet, Film Coated, Extended Release
Product Images NDC 24979-247

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Forfivo (NDC 24979-247). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Chemical structure diagram of bupropion hydrochloride, showing a chlorophenyl ring bonded to a ketone and tert-butyl group, representing the active ingredient in Forfivo XL 450 mg extended-release tablets.*

FDA Label Image

Label (Label)

Forfivo XL 450 mg extended-release tablets label showing it contains bupropion hydrochloride. The film-coated oral tablets are available in a 30-count package. Label includes dosing instructions, storage conditions (20°C to 25°C), warnings, and distributor information from TWI Pharmaceuticals USA, Inc. The labeler is Upsher-Smith Laboratories, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.